This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: University of California. Active years: 2010-2015.
Company Filing History:
Years Active: 2010-2015
Title: **Innovative Contributions of Charlie D Chen in Cancer Research**
Introduction
Charlie D Chen is an esteemed inventor based in Los Angeles, California, recognized for her significant contributions to the field of cancer research. With a total of four patents to her name, she has been instrumental in developing pioneering therapies to combat hyperproliferative disorders, particularly prostate cancer.
Latest Patents
Among her notable inventions, her latest patents encompass two groundbreaking developments. The first patent focuses on the "Treatment of hyperproliferative disorders with diarylhydantoin compounds," which presents innovative diarylhydantoin compounds and methods for synthesizing them. This invention aims to tackle hormone refractory prostate cancer, offering new treatment pathways. The second patent, titled "Methods and materials for assessing prostate cancer therapies," utilizes microarray-based profiling of isogenic prostate cancer xenograft models. This inventive method uncovered that a modest increase in androgen receptor (AR) mRNA is consistently linked with resistance to antiandrogen therapy, providing valuable insights into new therapeutic modalities.
Career Highlights
Charlie D Chen is currently associated with the University of California, where she continues her impactful research. Through her career, she has developed a reputation as a key innovator in developing therapies that target prostate cancer, showcasing her dedication and expertise in the field.
Collaborations
Throughout her research journey, Chen has collaborated with renowned scientists, including Charles L Sawyers and Michael E Jung. These collaborations have significantly contributed to the advancement of cancer therapy techniques and the understanding of prostate cancer resistance mechanisms.
Conclusion
In summary, Charlie D Chen stands out as a leading inventor in cancer treatment innovations, particularly in addressing hormone refractory prostate cancer. Her recent patents not only showcase her inventive prowess but also highlight her commitment to improving therapeutic options for patients. Through her work at the University of California and her collaborations with other experts, Chen continues to make substantial contributions to medical science and innovation.